Related Experiment Video
Updated: Aug 19, 2026

Non-invasive Imaging of Disseminated Candidiasis in Zebrafish Larvae
Published on: July 30, 2012
From Mendel to mycoses: Immuno-genomic warfare at the human-fungus interface
1Infectious Diseases - Hematology/Oncology/Transplant Clinical Program, Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada.
Abstract:
Fungi are opportunists: They particularly require a defect of immunity to cause severe or disseminated disease. While often secondary to an apparent iatrogenic cause, fungal diseases do occur in the absence of one, albeit infrequently. These rare cases may be due to an underlying genetic immunodeficiency that can present variably in age of onset, severity, or other infections, and in the absence of a family history of disease. They may also be due to anti-cytokine autoantibodies. This review provides a background on how human genetics or autoantibodies underlie cases of susceptibility to severe or disseminated fungal disease. Subsequently, the lessons learned from these inborn errors of immunity marked by fungal disease (IEI-FD) provide a framework to begin to mechanistically decipher fungal syndromes, potentially paving the way for precision therapy of the mycoses.
Insights
Severe fungal infections often stem from weakened immunity. Rare cases in healthy individuals may indicate genetic immunodeficiencies or autoantibodies, offering insights into fungal disease mechanisms and precision therapies.
Area of Science:
- Immunology
- Mycology
- Genetics
Background:
- Fungi typically cause severe disease when host immunity is compromised.
- In rare instances, severe fungal infections occur without obvious immune defects, suggesting underlying causes.
- These causes can include genetic immunodeficiencies or autoantibodies against cytokines.
Purpose of the Study:
- To review the genetic and autoantibody-driven mechanisms underlying susceptibility to severe fungal diseases.
- To explore how studying inborn errors of immunity marked by fungal disease (IEI-FD) can inform our understanding of fungal syndromes.
- To lay the groundwork for developing precision therapies for fungal infections.
Main Methods:
- Literature review of genetic immunodeficiencies and anti-cytokine autoantibodies associated with fungal infections.
- Analysis of case studies presenting with severe fungal disease in the absence of apparent immune compromise.
- Synthesis of findings to establish a framework for understanding IEI-FD.
Main Results:
- Identified genetic immunodeficiencies and anti-cytokine autoantibodies as key factors in rare severe fungal infections.
- Demonstrated variability in onset, severity, and associated infections among individuals with genetic immunodeficiencies.
- Highlighted the potential for IEI-FD to serve as models for deciphering fungal disease pathogenesis.
Conclusions:
- Human genetics and autoantibodies play critical roles in susceptibility to severe fungal infections.
- Understanding IEI-FD provides a valuable framework for mechanistic insights into fungal syndromes.
- This knowledge can potentially lead to targeted, precision-based therapeutic strategies for mycoses.
Related Concept Videos
Mutations in Microorganisms
Fungal Group Zygomycota
Fungal Phylum Microsporidia

